The cellular target of antidepressants.
Neuroscience iMed, AstraZeneca, Cambridge, Massachusetts, USA.
Nicholas J
NJ
Brandon
Lieber Institute for Brain Development, Baltimore, Maryland, USA.
Ron
R
McKay
D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology*; D003594:Cytoplasmic Granules / Q000187:drug effects*; D018891:Dentate Gyrus / Q000187:drug effects*; D005473:Fluoxetine / Q000494:pharmacology*; D044282:Receptor, Serotonin, 5-HT1A / Q000378:metabolism*
D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine; D044282:Receptor, Serotonin, 5-HT1A